SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 907.41 |
| Enterprise Value ($M) | 888.53 |
| Book Value ($M) | 74.07 |
| Book Value / Share | 0.77 |
| Price / Book | 12.25 |
| NCAV ($M) | 45.38 |
| NCAV / Share | 0.47 |
| Price / NCAV | 20.00 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.23 |
| Return on Assets (ROA) | -0.16 |
| Return on Equity (ROE) | -0.34 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.33 |
| Current Ratio | 2.73 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 139.26 |
| Assets | 167.95 |
| Liabilities | 93.88 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 169.12 |
| Operating Income | -42.40 |
| Net Income | -48.83 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -46.91 |
| Cash from Investing | 51.78 |
| Cash from Financing | 15.97 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 14.60 | 5.65 | |
| 13G/A | Rtw Investments, Lp | 0.00 | -100.00 | |
| 13G/A | Polar Capital Holdings Plc | 4.99 | -28.85 | |
| 13G/A | Cowen And Company, Llc | 0.00 | -100.00 | |
| 13G | BlackRock, Inc. | 5.50 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 281,201 | 1,212,785 | 23.19 | |
| 279,687 | 1,481,313 | 18.88 | |
| 420,228 | 2,315,582 | 18.15 | |
| 1,482,305 | 3,900,543 | 38.00 | |
| 336,959 | 1,025,512 | 32.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AUPH – Aurinia Pharmaceuticals Inc. | AURA – Aura Biosciences, Inc. |
| AVBP – ArriVent BioPharma, Inc. | AXSM – Axsome Therapeutics, Inc. |
| BCAB – BioAtla, Inc. |
Financial data and stock pages provided by
Fintel.io